BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20382523)

  • 1. Malnourished Malawian patients presenting with large Wilms tumours have a decreased vincristine clearance rate.
    Israels T; Damen CW; Cole M; van Geloven N; Boddy AV; Caron HN; Beijnen JH; Molyneux EM; Veal GJ
    Eur J Cancer; 2010 Jul; 46(10):1841-7. PubMed ID: 20382523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute malnutrition is common in Malawian patients with a Wilms tumour: A role for peanut butter.
    Israëls T; Borgstein E; Jamali M; de Kraker J; Caron HN; Molyneux EM
    Pediatr Blood Cancer; 2009 Dec; 53(7):1221-6. PubMed ID: 19821536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and toxicity of SIOP preoperative chemotherapy in Malawian children with a Wilms tumour.
    Israels T; Chagaluka G; Pidini D; Caron H; de Kraker J; Kamiza S; Borgstein E; Molyneux L
    Pediatr Blood Cancer; 2012 Oct; 59(4):636-41. PubMed ID: 22271712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group.
    Mitchell C; Pritchard-Jones K; Shannon R; Hutton C; Stevens S; Machin D; Imeson J; Kelsey A; Vujanic GM; Gornall P; Walker J; Taylor R; Sartori P; Hale J; Levitt G; Messahel B; Middleton H; Grundy R; Pritchard J;
    Eur J Cancer; 2006 Oct; 42(15):2554-62. PubMed ID: 16904312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional status at admission of children with cancer in Malawi.
    Israëls T; Chirambo C; Caron HN; Molyneux EM
    Pediatr Blood Cancer; 2008 Nov; 51(5):626-8. PubMed ID: 18668514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vincristine pharmacokinetics after repetitive dosing in children.
    Gidding CE; Meeuwsen-de Boer GJ; Koopmans P; Uges DR; Kamps WA; de Graaf SS
    Cancer Chemother Pharmacol; 1999; 44(3):203-9. PubMed ID: 10453721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative chemotherapy for patients with Wilms tumor in Malawi is feasible and efficacious.
    Israëls T; Molyneux EM; Caron HN; Jamali M; Banda K; Bras H; Kamiza S; Borgstein E; de Kraker J
    Pediatr Blood Cancer; 2009 Oct; 53(4):584-9. PubMed ID: 19533658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vincristine in childhood leukaemia: no pharmacokinetic rationale for dose reduction in adolescents.
    Frost BM; Lönnerholm G; Koopmans P; Abrahamsson J; Behrendtz M; Castor A; Forestier E; Uges DR; de Graaf SS
    Acta Paediatr; 2003 May; 92(5):551-7. PubMed ID: 12839283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal failure does not preclude cure in children receiving chemotherapy for Wilms tumor: a report from the National Wilms Tumor Study Group.
    Feusner JH; Ritchey ML; Norkool PA; Takashima JR; Breslow NE; Green DM
    Pediatr Blood Cancer; 2008 Feb; 50(2):242-5. PubMed ID: 17458877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of mixed adult Wilms' tumour and angiosarcoma responsive to carboplatin, etoposide and vincristine (CEO).
    Yau T; Leong CH; Chan WK; Chan JK; Liang RH; Epstein RJ
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):717-20. PubMed ID: 17571263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of vincristine monotherapy in childhood acute lymphoblastic leukemia.
    Groninger E; Meeuwsen-de Boar T; Koopmans P; Uges D; Sluiter W; Veerman A; Kamps W; de Graaf S
    Pediatr Res; 2002 Jul; 52(1):113-8. PubMed ID: 12084857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vincristine pharmacokinetics is related to clinical outcome in children with standard risk acute lymphoblastic leukemia.
    Lönnerholm G; Frost BM; Abrahamsson J; Behrendtz M; Castor A; Forestier E; Heyman M; Uges DR; de Graaf SS
    Br J Haematol; 2008 Aug; 142(4):616-21. PubMed ID: 18537965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of localised Wilms' tumour during preoperative chemotherapy is an independent prognostic factor: a report from the SIOP 93-01 nephroblastoma trial and study.
    Ora I; van Tinteren H; Bergeron C; de Kraker J;
    Eur J Cancer; 2007 Jan; 43(1):131-6. PubMed ID: 17084075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of paclitaxel in an anephric patient.
    Woo MH; Gregornik D; Shearer PD; Meyer WH; Relling MV
    Cancer Chemother Pharmacol; 1999; 43(1):92-6. PubMed ID: 9923547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic relevance of preoperative transcatheter arterial chemoembolization (TACE) and PCNA/VEGF expression in patients with Wilms' tumour.
    Liu WG; Gu WZ; Zhou YB; Tang HF; Li MJ; Ma WX
    Eur J Clin Invest; 2008 Dec; 38(12):931-8. PubMed ID: 19021718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wilms' tumour: adjuvant treatment with actinomycin D and vincristine.
    Jenkin RD; Jeffs RD; Stephens CA; Sonley MJ
    Can Med Assoc J; 1976 Jul; 115(2):136-40. PubMed ID: 179690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vincristine pharmacodynamics and pharmacogenetics in children with cancer: a limited-sampling, population modelling approach.
    Moore AS; Norris R; Price G; Nguyen T; Ni M; George R; van Breda K; Duley J; Charles B; Pinkerton R
    J Paediatr Child Health; 2011 Dec; 47(12):875-82. PubMed ID: 21658147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vincristine pharmacokinetics and response to vincristine monotherapy in an up-front window study of the Dutch Childhood Leukaemia Study Group (DCLSG).
    Groninger E; Meeuwsen-de Boer T; Koopmans P; Uges D; Sluiter W; Veerman A; Kamps W; de Graaf S
    Eur J Cancer; 2005 Jan; 41(1):98-103. PubMed ID: 15617994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group.
    Green DM; Cotton CA; Malogolowkin M; Breslow NE; Perlman E; Miser J; Ritchey ML; Thomas PR; Grundy PE; D'Angio GJ; Beckwith JB; Shamberger RC; Haase GM; Donaldson M; Weetman R; Coppes MJ; Shearer P; Coccia P; Kletzel M; Macklis R; Tomlinson G; Huff V; Newbury R; Weeks D
    Pediatr Blood Cancer; 2007 May; 48(5):493-9. PubMed ID: 16547940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study.
    Metzger ML; Stewart CF; Freeman BB; Billups CA; Hoffer FA; Wu J; Coppes MJ; Grant R; Chintagumpala M; Mullen EA; Alvarado C; Daw NC; Dome JS
    J Clin Oncol; 2007 Jul; 25(21):3130-6. PubMed ID: 17634492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.